Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

February 1, 1980; Volume 124,Issue 2
  • You have accessRestricted access
    Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
    M D Benson and E Kleiner
    J Immunol February 1, 1980, 124 (2) 495-499;
  • You have accessRestricted access
    The Fc gamma receptor on human placental plasma membrane. I. Studies on the binding of homologous and heterologous immunoglobulin G1.
    J A van der Meulen, T C McNabb, N Haeffner-Cavaillon, M Klein and K J Dorrington
    J Immunol February 1, 1980, 124 (2) 500-507;
  • You have accessRestricted access
    Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells.
    S Landolfo, M G Martinotti, P Martinetto and G Forni
    J Immunol February 1, 1980, 124 (2) 508-514;
  • You have accessRestricted access
    Ability of NZW but not NZB antigen-presenting cells to support T cell proliferative response to DNA methylated albumin.
    R Papoian and N Talal
    J Immunol February 1, 1980, 124 (2) 515-519;
  • You have accessRestricted access
    Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    R C Strunk and P C Giclas
    J Immunol February 1, 1980, 124 (2) 520-526;
  • You have accessRestricted access
    IgE-B cell generating factor from lymph node cells of rats infected with Nippostrongylus brasiliensis. III. Regulation of factor formation by anti-immunoglobulin.
    J F Urban Jr, K Ishizaka and H Bazin
    J Immunol February 1, 1980, 124 (2) 527-532;
  • You have accessRestricted access
    Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.
    K Ozato, N Mayer and D H Sachs
    J Immunol February 1, 1980, 124 (2) 533-540;
  • You have accessRestricted access
    Murine plasma cells secreting more than one class of immunoglobulin. VII. Analysis of the IgG2B and IgA precursors within the cytoplasm of spontaneous myeloma SAMM 368 in culture shows segregation of heavy chains.
    P E McKeever, M E Neiders, G B Nero and R Asofsky
    J Immunol February 1, 1980, 124 (2) 541-547;
  • You have accessRestricted access
    The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.
    W E Biddison, F E Ward, G M Shearer and S Shaw
    J Immunol February 1, 1980, 124 (2) 548-552;
  • You have accessRestricted access
    Inhibition of the immune response by Fc receptor-bound specific antibody on T lymphocytes.
    T M Setcavage and Y B Kim
    J Immunol February 1, 1980, 124 (2) 553-556;
  • You have accessRestricted access
    Radioimmunoassay for the P2 protein of bovine peripheral nerve myelin.
    H O Sarvas, D J Milek, M J Weise, T B Carnow, H H Fudenberg and S W Brostoff
    J Immunol February 1, 1980, 124 (2) 557-564;
  • You have accessRestricted access
    Conditions required for Fc-dependent immune complex enhancement of antigen-specific lymphocyte blastogenesis.
    E M Carvalho, J S Davis 4th and D A Horwitz
    J Immunol February 1, 1980, 124 (2) 565-570;
  • You have accessRestricted access
    On the mechanism of T cell-independent anti-Listeria resistance in nude mice.
    M F Newborg and R J North
    J Immunol February 1, 1980, 124 (2) 571-576;
  • You have accessRestricted access
    Contact hypersensitivity, humoral immunity, and specific unresponsiveness can be induced in Syrian hamsters with simple haptens.
    J W Streilein, S Sullivan and S Thompson
    J Immunol February 1, 1980, 124 (2) 577-585;
  • You have accessRestricted access
    The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1).
    S Slavin, S Morecki and L Weiss
    J Immunol February 1, 1980, 124 (2) 586-589;
  • You have accessRestricted access
    Restriction of antigen recognition in mouse B lymphocytes by genes mapping within the major histocompatibility complex.
    R M Gorczynski, M J Kennedy, S MacRae, E J Steele and A J Cunningham
    J Immunol February 1, 1980, 124 (2) 590-596;
  • You have accessRestricted access
    Differentiation of Thy 1-bearing cells from progenitors in long-term bone marrow cultures.
    E V Jones-Villeneuve, J J Rusthoven, R G Miller and R A Phillips
    J Immunol February 1, 1980, 124 (2) 597-601;
  • You have accessRestricted access
    Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.
    R G Medicus, A F Esser, H N Fernandez and H J Müller-Eberhard
    J Immunol February 1, 1980, 124 (2) 602-606;
  • You have accessRestricted access
    Cellular events in tolerance. VIII. Analysis of the proliferative capacity of antigen-binding cells isolated from normal or tolerant spleens.
    M Venkataraman and D W Scott
    J Immunol February 1, 1980, 124 (2) 607-610;
  • You have accessRestricted access
    Adoptive transfer of spleen cells from mice treated with radioactive strontium: suppressor cells, natural killer cells, and "hybrid resistance" in recipient mice.
    E M Levy, M Bennett, V Kumar, P Fitzgerald and S R Cooperband
    J Immunol February 1, 1980, 124 (2) 611-618;
  • You have accessRestricted access
    Genetic control of the immune response to myoglobin. III. Determinant-specific, two Ir gene phenotype is regulated by the genotype of reconstituting Kupffer cells.
    L R Richman, W Strober and J A Berzofsky
    J Immunol February 1, 1980, 124 (2) 619-625;
  • You have accessRestricted access
    Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones.
    S I Schlager and S H Ohanian
    J Immunol February 1, 1980, 124 (2) 626-634;
  • You have accessRestricted access
    Lipopolysaccharide-induced immunomodulation of the generation of cell-mediated cytotoxicity. I. Suppression of the development of cytotoxic lymphocytes.
    D A Vallera, U Pflugfelder and J R Schmidtke
    J Immunol February 1, 1980, 124 (2) 635-640;
  • You have accessRestricted access
    Lipopolysaccharide-induced immunomodulation of the generation cell-mediated cytotoxicity. II. Evidence for the involvement of a regulatory B lymphocyte.
    D A Vallera, C E Gamble and J R Schmidtke
    J Immunol February 1, 1980, 124 (2) 641-649;
  • You have accessRestricted access
    Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter.
    M R Tam, S L Emmons and S B Pollack
    J Immunol February 1, 1980, 124 (2) 650-655;
  • You have accessRestricted access
    Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I.
    J Pryjma, J Muñoz, R M Galbraith, H H Fudenberg and G Virella
    J Immunol February 1, 1980, 124 (2) 656-661;
  • You have accessRestricted access
    Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    G Parmiani, D Ballinari and M L Sensi
    J Immunol February 1, 1980, 124 (2) 662-668;
  • You have accessRestricted access
    Murine immunogenicity of N-substituted phosphatidylethanolamine derivatives in liposomes: response to the hapten phosphocholine.
    J L Honegger, P C Isakson and S C Kinsky
    J Immunol February 1, 1980, 124 (2) 669-675;
  • You have accessRestricted access
    Human neutrophil-derived platelet activating factor.
    G Z Lotner, J M Lynch, S J Betz and P M Henson
    J Immunol February 1, 1980, 124 (2) 676-684;
  • You have accessRestricted access
    Complement receptors on guinea pig epidermal Langerhans cells.
    B Berman and I Gigli
    J Immunol February 1, 1980, 124 (2) 685-690;
  • You have accessRestricted access
    Preparation and characterization of anti-framework antibodies to the kappa-chain variable region (V kappa) of mouse immunoglobulins.
    Y Ben-Neriah, P Lonai and D Givol
    J Immunol February 1, 1980, 124 (2) 691-695;
  • You have accessRestricted access
    Characterization of in vitro T lymphocyte colonies from normal mouse spleen cells: colonies containing cytotoxic lymphocyte precursors.
    L M Ching and R G Miller
    J Immunol February 1, 1980, 124 (2) 696-701;
  • You have accessRestricted access
    Functional properties of human T cells bearing Fc receptors for IgA. I. Mitogen responsiveness, mixed lymphocyte culture reactivity, and helper activity for B cell immunoglobulin production.
    L G Lum, E Benveniste and R M Blaese
    J Immunol February 1, 1980, 124 (2) 702-707;
  • You have accessRestricted access
    Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS).
    D J Cameron and W H Churchill
    J Immunol February 1, 1980, 124 (2) 708-712;
  • You have accessRestricted access
    Cells treated with trinitrobenzene sulfonic acid express an antigenic determinant recognized by cytotoxic effector cells that is not detected on cells coated with trinitrophenylated proteins.
    R Ciavarra and J Forman
    J Immunol February 1, 1980, 124 (2) 713-718;
  • You have accessRestricted access
    The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    R M de Waal, P J Capel and R A Koene
    J Immunol February 1, 1980, 124 (2) 719-723;
  • You have accessRestricted access
    Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
    A H Hale, D S Lyles and D P Fan
    J Immunol February 1, 1980, 124 (2) 724-731;
  • You have accessRestricted access
    Surface antigens of murine hemopoietic stem cells. II. Rosetting method used to compare the cross-reactivity of antisera against mouse brain, sperm, and testis cells with bone marrow stem cells and progenitor cells.
    M V Berridge and N Okech
    J Immunol February 1, 1980, 124 (2) 732-738;
  • You have accessRestricted access
    The role of insulin in the response of murine T lymphocytes to mitogenic stimulation in vitro.
    E C Snow, T L Feldbush and J A Oaks
    J Immunol February 1, 1980, 124 (2) 739-744;
  • You have accessRestricted access
    The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    D A Thorley-Lawson
    J Immunol February 1, 1980, 124 (2) 745-751;
  • You have accessRestricted access
    A restricted component of T cell help in pokeweed mitogen-stimulated humans peripheral blood cell cultures.
    E Macy and R H Stevens
    J Immunol February 1, 1980, 124 (2) 752-759;
  • You have accessRestricted access
    Isolation of pemphigus antigen from human saliva.
    L A Diaz, H Patel and N J Calvanico
    J Immunol February 1, 1980, 124 (2) 760-765;
  • You have accessRestricted access
    A hybridoma from an autoimmune NZB/NZW mouse producing monoclonal antibody to ribosomal-RNA.
    D Eilat, R Asofsky and R Laskov
    J Immunol February 1, 1980, 124 (2) 766-768;
  • You have accessRestricted access
    The preparation of rabbit antiserum specific for mammalian testicular sulfogalactoglycerolipid.
    C A Lingwood, R K Murray and H Schachter
    J Immunol February 1, 1980, 124 (2) 769-774;
  • You have accessRestricted access
    Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity.
    Z Eshhar, M Ofarim and T Waks
    J Immunol February 1, 1980, 124 (2) 775-780;
  • You have accessRestricted access
    Hydroxyurea kills B cell precursors and markedly reduces functional B cell activity in mouse bone marrow.
    J J Rusthoven and R A Phillips
    J Immunol February 1, 1980, 124 (2) 781-786;
  • You have accessRestricted access
    Antibody gene linkage studies in (NZB X C58) recombinant-inbred lines.
    R Riblet, L Claflin, D M Gibson, B J Mathieson and M Weigert
    J Immunol February 1, 1980, 124 (2) 787-789;
  • You have accessRestricted access
    Delayed-type hypersensitivity to liver F antigen in the mouse.
    P C Cooper, M F Coffey, R F Anders and I R MacKay
    J Immunol February 1, 1980, 124 (2) 790-794;
  • You have accessRestricted access
    Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over Staphylococcus aureus Cowans I. I. Description of acute tumoricidal response: morphologic, histologic, immunohistochemical, immunologic, and serologic findings.
    D S Terman, T Yamamoto, M Mattioli, G Cook, R Tillquist, J Henry, R Poser and Y Daskal
    J Immunol February 1, 1980, 124 (2) 795-805;
  • You have accessRestricted access
    Tegument-associated antigen modulation by adult male Schistosoma mansoni.
    W M Kemp, P R Brown, S C Merritt and R E Miller
    J Immunol February 1, 1980, 124 (2) 806-811;
  • You have accessRestricted access
    Effect of 89Sr on immunity and autoimmunity in NZB/NZW F1 mice.
    W E Seaman, M A Blackman, J S Greenspan and N Talal
    J Immunol February 1, 1980, 124 (2) 812-818;
  • You have accessRestricted access
    Regulation of IgE antibody production by serum molecules. VII. The IgE-selective damping activity of suppressive factor of allergy (SFA) is exerted across both strain and species restriction barriers.
    D H Katz, R F Bargatze, C A Bogowitz and L R Katz
    J Immunol February 1, 1980, 124 (2) 819-824;
  • You have accessRestricted access
    Lymphoid sources of murine migration inhibition factor.
    N E Adelman, J Ksiazek, T Yoshida and S Cohen
    J Immunol February 1, 1980, 124 (2) 825-830;
  • You have accessRestricted access
    Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    M B Oldstone, M J Buchmeier, M V Doyle and A Tishon
    J Immunol February 1, 1980, 124 (2) 831-838;
  • You have accessRestricted access
    Susceptibility of proliferating cytolytic T lymphocytes to 33258 Hoechst-modified BUdR and light treatment: quantitation of the residual precursor cells by limiting dilution analysis.
    J L Maryanski, J C Cerottini and K T Brunner
    J Immunol February 1, 1980, 124 (2) 839-845;
  • You have accessRestricted access
    T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
    J C Leclerc and H Cantor
    J Immunol February 1, 1980, 124 (2) 846-850;
  • You have accessRestricted access
    T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
    J C Leclerc and H Cantor
    J Immunol February 1, 1980, 124 (2) 851-854;
  • You have accessRestricted access
    The sequential release of granule constitutents from human neutrophils.
    B J Bentwood and P M Henson
    J Immunol February 1, 1980, 124 (2) 855-862;
  • You have accessRestricted access
    The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    H Fujiwara, T Hamaoka, G M Shearer, H Yamamoto and W D Terry
    J Immunol February 1, 1980, 124 (2) 863-869;
  • You have accessRestricted access
    The mechanism of cell-mediated cytotoxicity. I. Killing by murine cytotoxic T lymphocytes requires cell surface thiols and activated proteases.
    D Redelman and D Hudig
    J Immunol February 1, 1980, 124 (2) 870-878;
  • You have accessRestricted access
    Concentration of IgG1 and IgG2a allotypes in serum of nude and normal allotype-congenic mice.
    G C Bosma, J Owen, G Easton, G Marshall, C Dewitt and M J Bosma
    J Immunol February 1, 1980, 124 (2) 879-884;
  • You have accessRestricted access
    The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    A A Gottlieb, G A Maziarz, N Tamaki and S B Sutcliffe
    J Immunol February 1, 1980, 124 (2) 885-892;
  • You have accessRestricted access
    Accelerated loss and replacement of receptors on antigen-binding cells after immunization.
    R F Ashman
    J Immunol February 1, 1980, 124 (2) 893-901;
  • You have accessRestricted access
    Immunoglobulin synthesis by T cells: quantitative and qualitative aspects.
    D Putnam, J Clagett and U Storb
    J Immunol February 1, 1980, 124 (2) 902-912;
  • You have accessRestricted access
    Mapping of lymphocyte surface polypeptide antigens by chemical cross-linking with BSOCOES.
    D A Zarling, A Watson and F H Bach
    J Immunol February 1, 1980, 124 (2) 913-920;
  • You have accessRestricted access
    Mitogenic effect on human lymphocytes of insolubilized anti-immunoglobulins. I. Specificity of the stimulating agent.
    A Henriksen, T Godal and T O Landaas
    J Immunol February 1, 1980, 124 (2) 921-925;
  • You have accessRestricted access
    The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs).
    E J Goetzl, P F Weller and F F Sun
    J Immunol February 1, 1980, 124 (2) 926-933;
  • You have accessRestricted access
    Induction of Fc epsilon-receptor bearing cells in vitro in human peripheral lymphocytes.
    J Yodoi and K Ishizaka
    J Immunol February 1, 1980, 124 (2) 934-938;
  • You have accessRestricted access
    Induction of anti-ssDNA antibodies in normal and preautoimmune mice in vivo.
    L B Pancer, D A Bell and S K Singhal
    J Immunol February 1, 1980, 124 (2) 939-946;
  • You have accessRestricted access
    Characterization of murine colony-forming B cells. II. Limits to in vitro maturation, Lyb-2 expression, resolution of IgD+ subsets, and further population analysis.
    P W Kincade, G Lee, M P Scheid and M D Blum
    J Immunol February 1, 1980, 124 (2) 947-953;
  • You have accessRestricted access
    Permeability changes induced in erthrocyte ghost targets by antibody-dependent cytotoxic effector cells: evidence for membrane pores.
    C B Simone and P Henkart
    J Immunol February 1, 1980, 124 (2) 954-963;
  • You have accessRestricted access
    The influence of incubation time and mitogen concentration on lymphocyte blastogenic response: determination of conditions that maximize population differences.
    M I Bernhard, R C Pace, S W Unger and H J Wanebo
    J Immunol February 1, 1980, 124 (2) 964-968;
  • You have accessRestricted access
    THY1 antigen and B lymphocyte differentiation in the rat.
    J M Crawford and I Goldschneider
    J Immunol February 1, 1980, 124 (2) 969-976;
  • You have accessRestricted access
    Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
    M K Pangburn, D C Morrison, R D Schreiber and H J Müller-Eberhard
    J Immunol February 1, 1980, 124 (2) 977-982;
  • You have accessRestricted access
    Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.
    Z Metzger, J T Hoffeld and J J Oppenheim
    J Immunol February 1, 1980, 124 (2) 983-988;
  • You have accessRestricted access
    Role of accessory cells in B cell activation. I. Macrophage presentation of TNP-Ficoll: evidence for macrophage-B cell interaction.
    H S Boswell, S O Sharrow and A Singer
    J Immunol February 1, 1980, 124 (2) 989-996;
  • You have accessRestricted access
    Identification and characterization of protein antigens of two mycoplasma species.
    P B Asa, R T Acton, G H Cassell and K S Wise
    J Immunol February 1, 1980, 124 (2) 997-999;
  • You have accessRestricted access
    Monoclonal antibodies detect antigenic diversity in Theileria parva parasites.
    M Pinder and R S Hewett
    J Immunol February 1, 1980, 124 (2) 1000-1001;
  • You have accessRestricted access
    The two high responder haplotypes to (TG)-A--L do not cross-react in the helper T cell level.
    P Marrack and J W Kappler
    J Immunol February 1, 1980, 124 (2) 1002-1004;

ERRATA

  • You have accessRestricted access
    Author Index
    E Abdel-Salam
    J Immunol February 1, 1980, 124 (2) 1006;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 124, Issue 2
1 Feb 1980
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ERRATA
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606